Verapamil Drug Interactions: What to Avoid and What to Tell Your Doctor

Verapamil is a potent drug with a significant interaction profile. Because it slows heart conduction, inhibits a key liver enzyme (CYP3A4), and affects multiple body systems, it interacts with dozens of medications. Some of these interactions are dangerous — even life-threatening. Here's what you need to know before starting verapamil, and what to discuss with your prescriber.

Why Does Verapamil Have So Many Drug Interactions?

Verapamil interacts with other drugs for two main reasons:

Pharmacodynamic interactions — Verapamil slows the heart rate and AV conduction. Combining it with other drugs that also slow the heart (beta-blockers, other antiarrhythmics, digoxin) can cause additive effects: dangerously slow heartbeat, AV block, or cardiac arrest.

CYP3A4 inhibition — Verapamil inhibits the CYP3A4 enzyme, which metabolizes many other drugs. When CYP3A4 is inhibited, those drugs accumulate to higher-than-expected levels, increasing their effects and side effects.

Major Drug Interactions: Potentially Dangerous

These interactions are clinically significant and may require avoiding the combination or close monitoring:

Beta-blockers (metoprolol, atenolol, propranolol, carvedilol, etc.): Both verapamil and beta-blockers slow the heart rate and AV conduction. The combination can cause severe bradycardia (dangerously slow heart rate), AV block, and heart failure. IV verapamil and IV beta-blockers should NEVER be given together — this can cause cardiac arrest. Oral combinations require very close monitoring and should only be prescribed under cardiac supervision.

Digoxin: Verapamil increases digoxin blood levels by 50–75% by inhibiting the P-glycoprotein transporter. This can cause digoxin toxicity: nausea, vision changes (yellow/green halos), arrhythmias. When starting verapamil in a patient on digoxin, digoxin dose reduction and blood level monitoring are required.

Amiodarone: Combining verapamil with amiodarone (another antiarrhythmic) can cause severe bradycardia, AV block, and myocardial depression. This combination is generally avoided.

Dofetilide: Verapamil is contraindicated with dofetilide (Tikosyn). CYP3A4 inhibition increases dofetilide levels, significantly raising the risk of dangerous QT prolongation and torsades de pointes.

Colchicine: Verapamil inhibits both CYP3A4 and P-glycoprotein, which are responsible for colchicine metabolism. Co-administration significantly increases colchicine plasma levels, potentially causing severe colchicine toxicity (multi-organ failure, bone marrow suppression). Colchicine dose reduction is required, or the combination should be avoided.

Simvastatin and lovastatin: CYP3A4 inhibition by verapamil raises simvastatin and lovastatin blood levels, dramatically increasing the risk of myopathy and rhabdomyolysis (muscle breakdown). If a statin is needed while taking verapamil, pravastatin, rosuvastatin, or fluvastatin are preferred as they are less affected by CYP3A4 inhibition.

Moderate Drug Interactions: Require Monitoring or Dose Adjustment

Lithium: Verapamil can alter lithium blood levels — in some cases lowering them (reducing efficacy) and in others causing neurotoxicity despite normal lithium levels. Patients on both drugs need more frequent lithium level monitoring.

Carbamazepine (Tegretol): CYP3A4 inhibition by verapamil increases carbamazepine levels, increasing the risk of carbamazepine toxicity (double vision, dizziness, ataxia). Monitor carbamazepine levels.

Cyclosporine: Verapamil can increase cyclosporine levels significantly; may increase immunosuppression and nephrotoxicity. Monitor cyclosporine blood levels.

Theophylline: CYP3A4 inhibition raises theophylline levels, increasing the risk of toxicity (nausea, seizures, arrhythmias).

Phenytoin, phenobarbital, rifampin: These drugs induce CYP3A4, which increases verapamil metabolism — reducing verapamil blood levels and its therapeutic effect. May need higher verapamil doses.

Cimetidine (Tagamet): Can increase verapamil blood levels; may need dose adjustment.

Alcohol: Verapamil can prolong and intensify the effects of alcohol, including increased hypotension, dizziness, and impaired coordination. Alcohol should be used with caution.

Food Interaction: Grapefruit

Grapefruit and grapefruit juice are a well-documented concern with verapamil. Compounds in grapefruit (furanocoumarins) inhibit CYP3A4 in the intestinal wall, which reduces the first-pass metabolism of verapamil. The result: verapamil blood levels increase significantly, potentially causing bradycardia, hypotension, and other side effects. Avoid grapefruit and grapefruit juice entirely while taking verapamil.

Herbal Supplement Interaction: St. John's Wort

St. John's Wort is a CYP3A4 inducer — it ramps up the enzyme that breaks down verapamil. Taking St. John's Wort reduces verapamil blood levels, potentially making the medication less effective for blood pressure control or arrhythmia management. Always tell your prescriber about herbal supplements.

What to Tell Your Doctor Before Starting Verapamil

Before starting verapamil, provide your prescriber with a complete list of:

All prescription medications — especially any heart medications (beta-blockers, digoxin, other antiarrhythmics)

All over-the-counter medications, including cimetidine (heartburn)

All herbal supplements, especially St. John's Wort

Any history of kidney or liver disease, which affects verapamil metabolism

To learn more about verapamil, see Verapamil Side Effects: What to Expect and When to Call Your Doctor and What Is Verapamil? Uses, Dosage, and What You Need to Know in 2026.